Position in NVO
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$815,794
+$509,593 QoQ
Shares Held
17,017
+104.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#569
of 1,348 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focus Financial Network, Inc. holds $24,753,485 across 11 Drug Manufacturers - General names. NVO ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,014 | $8,412,802 | |
| 2 | JNJ |
Johnson & Johnson
|
26,353 | $6,692,871 | |
| 3 | ABBV |
AbbVie Inc.
|
16,133 | $4,059,708 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,855 | $1,394,867 | |
| 5 | AMGN |
Amgen Inc
|
3,743 | $1,355,415 | |
| 6 | PFE |
Pfizer Inc
|
44,319 | $1,067,201 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
17,017 | $815,794 | |
| 8 | NVS |
Novartis AG
|
2,032 | $318,455 |
All Filings in NVO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $815,794 | 17,017 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $306,201 | 8,332 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $393,404 | 7,732 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $330,942 | 5,964 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $383,682 | 5,559 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $446,152 | 6,425 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $762,997 | 8,870 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $966,848 | 8,120 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,126,646 | 7,893 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $514,627 | 4,008 | Shares | Sole | 2024-04-24 | |
| 2023-09-30 | $260,088 | 2,860 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||